New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG)

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
354
New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) Eyes Bolivia’s Untapped Silver Potential Amid Global Supply Gaps

- Bolivia, despite its rich mining history, remains one of the most underexplored silver jurisdictions due to a slow permitting process, but investors may benefit from dramatic upside if reforms advance.
- New Pacific Metals holds two of the most promising undeveloped silver projects globally in the country: Silver Sand and Carangas.
- Together, the two projects could position New Pacific among the top global primary silver producers, with potential combined output of nearly 19 million ounces annually when production begins.
- Backing from mining companies Silvercorp and Pan American Silver signals confidence in long-term development.

As global demand for silver intensifies, largely fueled by industrial applications such as solar panels and electric vehicles, supply remains constrained. Few new primary silver projects are advancing, leaving producers searching for untapped potential. For New Pacific Metals (NYSE American: NEWP) (TSX: NUAG), a Canadian exploration and development company, that opportunity lies in Bolivia, a country with deep silver reserves, but limited modern development.

Bolivia is geologically rich, with a long and significant silver history, but is currently underexplored. Due to a decade of slow-moving regulatory frameworks and limited foreign investment, the country has lagged behind more active mining jurisdictions. Still, there is growing recognition within Bolivia of the need to attract external capital to reignite its mining sector. With fiscal deficit hovering around 10% in recent years, foreign direct investment is increasingly seen as a way to strengthen the economy. This environment may mark a potential turning point for companies willing to operate in a higher-risk jurisdiction with significant untapped geological potential.

New Pacific Metals has positioned itself as a first mover in this environment. The company’s flagship Silver Sand project is among the most advanced silver developments in Bolivia. A preliminary feasibility study released in June 2024 outlines a 13-year mine life producing 12 million ounces of silver annually, 15 million ounces in the initial years. The economics are robust: at a silver price of US$24 per ounce, the project yields a post-tax NPV of US$740 million and a 37% IRR, with an all-in sustaining cost (“AISC”) of just US$10.69 per ounce. Payback is expected in under two years.

Meanwhile, the company’s second project, Carangas, expands its silver footprint even further. A preliminary economic assessment from September 2024 projects annual output of 6.6 million ounces of silver over a 16-year lifespan. Carangas also boasts favorable economics: US$501 million post-tax NPV, 26% IRR, and AISC of US$7.60, after accounting for lead and zinc by-product credits. Significantly, Carangas has over 1 million ounces of gold mineralization at depth, not yet factored into its economics, offering future upside.

Together, Silver Sand and Carangas could position New Pacific among the top global primary silver producers, with potential combined output of nearly 19 million ounces annually when production begins.

Bolivia presents challenges, with political uncertainty, regulatory delays, and untested permitting frameworks making project timelines less predictable. However, if the country could implement even modest reforms, the payoffs for early investors could be considerable.

Major shareholders see the same potential. New Pacific is 28% owned by Silvercorp Metals (NYSE-A: SVM) (TSX: SVM), a Canadian mining company producing silver, gold, lead, and zinc with a long history of profitability, and 13% owned by Pan American Silver (NYSE: PAAS) (TSX: PAAS), which describes itself as the world’s top silver producer. Their presence lends support and hints at possible strategic moves, either toward project development or future acquisition.

The market backdrop is also compelling. According to the World Silver Survey, industrial applications now account for 60% of annual silver demand (https://nnw.fm/LOJHe ). As the transition to clean energy accelerates, the demand for silver in solar technology and battery applications is expected to rise, in addition to the growing appeal of silver as a bullion investment.

In spite of demands, few new high-grade, low-cost silver projects are coming online. That scarcity underscores the importance of projects like Silver Sand and Carangas. With promising geology, supportive shareholders, and improving local sentiment toward investment, New Pacific offers exposure to one of the last relatively untapped silver frontiers. Success will depend not just on ore grades or economics, but also on navigating Bolivia’s regulatory environment, yet the potential rewards are seen as significant.

For more information, visit the company’s website at www.NewPacificMetals.com.

NOTE TO INVESTORS: The latest news and updates relating to NEWP are available in the company’s newsroom at https://nnw.fm/NEWP

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer

New Pacific Metals Corp. (NEWP) Stock Research Links

NEWP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 313

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 193

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 128

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 130

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 224

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 332

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 134

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 541

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 161

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading

Top 5 Most Recently Viewed Articles

Phreesia Announces Q3 Fiscal Year 2025 Financial Results

Updated Category News Views 71

Phreesia to Release Fiscal Q3 2025 Results Soon Phreesia, Inc. (NYSE: PHR) has great news for its stakeholders! The company revealed plans to announce its financial results for the third quarter of fiscal year 2025 right after market closing on a Monday in December. During this quarter, the firm experienced substantial growth and is eager to share the details with the...

Continue Reading
Innovative Water Bowl Design Enhances Pet Hydration Experience

Updated Category News Views 374

Revolutionary Pet Water Bowl Crafted for Optimal Hydration Every pet owner knows the importance of keeping their furry friends hydrated, especially during hot days. A new invention promises to enhance the experience for pets and their owners alike. This innovative water bowl, known as the THERMA DRINK, is designed with features that cater directly to pet needs. The idea...

Continue Reading
HPH's Leadership Changes Signify Strategic Direction Ahead

Updated Category News Views 177

Leadership Transitions at HPH Highest Performances Holdings Inc. (NASDAQ: HPH) has recently seen a notable change in its Board of Directors. The company announced that Mr. Peh Chin Hua's tenure as Director has come to an end, effective immediately. This decision is part of a broader strategy aimed at strengthening the Board's overall composition and capabilities. Current...

Continue Reading
Apranga Group Reports Growth in Retail Turnover for 2025

Updated Category News Views 132

Apranga Group Retail Performance Overview for 2025 Apranga Group, a major player in the retail sector, has announced its impressive financial performance for the first six months of 2025, demonstrating notable growth compared to the prior year. The company's retail turnover reached a commendable EUR 166.1 million, reflecting a 2.8% increase from the same period in 2024....

Continue Reading
IMUNON Unveils Promising New Vaccine Data for COVID-19

Updated Category News Views 154

New Vaccine Insights from IMUNON's Phase 1 Clinical Trial The innovative PlaCCine technology platform developed by IMUNON, Inc. (NASDAQ: IMNN) promises remarkable durability and advantages over traditional mRNA vaccines, particularly in the struggle against COVID-19. Robust Results from IMNN-101 Vaccine Trials In an encouraging announcement, IMUNON shared pivotal data...

Continue Reading